Last10K.com

Premier Biomedical Inc (BIEI) SEC Filing 10-Q Quarterly report for the period ending Monday, September 30, 2019

Premier Biomedical Inc

CIK: 1515740 Ticker: BIEI
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2019
Nov. 12, 2019
Document And Entity Information  
Entity Registrant NamePREMIER BIOMEDICAL INC 
Entity Central Index Key0001515740 
Document Type10-Q 
Document Period End DateSep. 30, 2019 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Is Entity's Reporting Status CurrentYes 
Entity Filer CategoryNon-accelerated Filer 
Entity Emerging Growth Companytrue 
Entity Ex Transition Periodfalse 
Entity Small Businesstrue 
Entity Shell Companyfalse 
Entity Common Stock, Shares Outstanding 186,961,480
Document Fiscal Period FocusQ3 
Document Fiscal Year Focus2019 

View differences made from one quarter to another to evaluate Premier Biomedical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Premier Biomedical Inc.

Continue

Assess how Premier Biomedical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Premier Biomedical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: BIEI
CIK: 1515740
Form Type: 10-Q Quarterly Report
Accession Number: 0001654954-19-013012
Submitted to the SEC: Thu Nov 14 2019 4:46:51 PM EST
Accepted by the SEC: Thu Nov 14 2019
Period: Monday, September 30, 2019
Industry: Biological Products No Disgnostic Substances

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/biei/0001654954-19-013012.htm